IP Library › Granted Patent US 12,391,917
Granted Patent B2
US 12,391,917 · App. 17/040,730 · Granted Aug 19, 2025

Method for isolating stem cells from human umbilical cord

Inventors: Hyun Chul Jo (Seoul, KR); Ah-Young Lee (Gyeonggi-do, KR)
Assignee: ACESOSTEM BIOSTRATEGIES INC.
C12N5/0605A61K35/51C12N5/0653C12N5/0654C12N5/0655C12N5/066C12N2506/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,391,917
App. No.
17/040,730
Granted
Aug 19, 2025
Kind
B2
Abstract

The present invention relates to a method for isolating umbilical cord-derived stem cells, and more specifically to a method for isolating a significantly large number of mesenchymal stem cells from the umbilical cord having a specified size. The method of the present invention has a great advantage in that since stem cells can be isolated from an umbilical cord tissue without enzymatic treatment, stress applied to the cells can be significantly suppressed. In addition, stem cells obtained by the method of the present invention have superior proliferative capacity compared to stem cells obtained by conventional isolation methods.

Claims (9)

1. A method for isolating stem cells from umbilical cord tissue comprising:

(a) grinding the umbilical cord tissue into hexahedral explants having a width of 2 to 4 mm, a length of 2 to 4 mm, and a height of 2 to 4 mm;

(b) seeding the explants to a culture dish and culturing the explants in a first culture medium to reach 0.0007 to 0.0068 g per unit area of the culture dish as measured in cm 2 without enzymatic treatment; and

(c) collecting the stem cells after culture;

wherein step (a) further comprises introducing the umbilical cord tissue into a second culture medium before grinding the isolated umbilical cord tissue and the second culture medium is added in an amount of 0.5 to 3.0 ml per gram of the umbilical cord tissue;

wherein adherence time of the explants to the culture dish in step (b) is carried out for 60 to 120 minutes.

2. The method according to claim 1 , wherein step (c) is carried out when the stem cells are cultured to cover 60 to 90% of the surface area of the culture dish.

3. The method according to claim 1 , wherein step (c) is carried out by treatment with trypsin-EDTA.

4. The method according to claim 1 , wherein the first culture medium is selected from the group consisting of Dulbecco's minimum essential medium (DMEM), RPMI, Ham's F-10, Ham's F-12, α-minimal essential medium (α-MEM), Glasgow's minimal essential medium (GMEM), Iscove's modified Dulbecco's medium (IMDM), and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: JO, HYUN CHUL; LEE, AH-YOUNG
To: ACESOSTEM BIOSTRATEGIES INC.
Reel/Frame 053859/0527 →
Priority Claims (1)
KR 10-2018-0036230 · Mar 29, 2018 · national
Continuity (1)
Related Publication 20210009944A1 · Jan 14, 2021
References Cited (27)
CN 102220338 · 2011 [cited by applicant]
CN 104232574 · 2014 [cited by applicant]
CN 105420179 · 2016 [cited by applicant]
KR 1020080081053 · 2008 [cited by applicant]
KR 1020090008784 · 2009 [cited by applicant]
KR 1020110134253 · 2011 [cited by applicant]
KR 1020150016117 · 2015 [cited by applicant]
KR 1020170108325 · 2017 [cited by applicant]
WO WO2018067071A1 · 2018 [cited by examiner]
Filiz et al., Positive correlation between the quantity of Wharton's jelly in the umbilical cord and birth weight , Taiwanese Journal of Obstetrics & Gynecology 50 (2011) pp. 33-36 (Year: 2011). [cited by examiner]
Mori et al., Improved Explant Method to Isolate Umbilical Cord-Derived Mesenchymal Stem Cells and Their Immunosuppressive Properties, Tissue Engineering Part C: Methods. Apr.367-372. (Year: 2015). [cited by examiner]
Capelli, Chiara, et al. “Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate.” Cytotherapy 13.7 (2011): 786-801. (Year: 2… [cited by examiner]
Filiz, Avsar A., et al. “Positive correlation between the quantity of Wharton's jelly in the umbilical cord and birth weight.” Taiwanese Journal of Obstetrics and Gynecology 50.1 (2011): 33-36. (Year: 2011). [cited by examiner]
Ryu, Hak-Hyun, et al. “Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs.” Journal of Veterinary Medical Science 74.1… [cited by examiner]
Mori, Yuka, et al. “Improved explant method to isolate umbilical cord-derived mesenchymal stem cells and their immunosuppressive properties.” Tissue Engineering Part C: Methods 21.4 (2015): 367-372. (Year: 2015). [cited by examiner]
Egger, D.; Tripisciano, C.; Weber, V.; Dominici, M.; Kasper, C. Dynamic Cultivation of Mesenchymal Stem Cell Aggregates. Bioengineering 2018, 5, 48. (Year: 2018). [cited by examiner]
Paladino, F.V., et al., “Comparison between isolation protocols highlights intrinsic variability of human umbilical cord mesenchymal cells,” Cell Tissue Bank, 2016, 17, 123-136. [cited by applicant]
Hassan, G., et al., “A Simple Method to Isolate and Expand Human Umbilical Cord Derived Mesenchymal Stem Cells: Using Explant Method and Umbilical Cord Blood Serum,” International Journal of Stem Cells, 2017, vol. 10, N… [cited by applicant]
Mennan, C., et al., “Isolation and Characterisation of Mesenchymal Stem Cells from Different Regions of the Human Umbilical Cord,” BioMed Research International, 2013, vol. 2013, Article ID 916136, 8 pages. [cited by applicant]
Lee, H.R., et al., “Cryopreservation of Umbilical Cord as a Source of Mesenchymal Stromal Cells and Growth Factors,” Korean J Blood Transfus. Aug. 2012;23(2):115-126. [cited by applicant]
Hua, J., et al., “Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: Proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilic… [cited by applicant]
Montanucci, P., et al., “New Simple and Rapid Method for Purification of Mesenchymal Stem Cells from the Human Umbilical Cord Wharton Jelly,” Tissue Eng Part A. Nov. 2011;17(21-22):2651-61. [cited by applicant]
Kim, S.M., et al., “Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells,” Stem Cells Dev. Nov. 15, 2013;22(22):3025-38. [cited by applicant]
Yan, M., et al., “Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease … [cited by applicant]
Chatzistamatiou, T.K., et al., “Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank… [cited by applicant]
Yoon, J.H., et al., “Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton's jelly,” Biomed Res Int. 2013;2013:428726. [cited by applicant]
Jo, C.H., et al., “Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion,” Cell Tissue Res. Dec. 2008;334(3):423-33. [cited by applicant]